You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 28, 2024

CLINICAL TRIALS PROFILE FOR REGRANEX


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for REGRANEX

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00034788 ↗ A Study on the Efficacy and Safety of Long-Term Treatment and Re-Treatment of Lower Extremity Diabetic Ulcers With REGRANEX Terminated Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Phase 3 2000-12-01 The purpose of this study is to evaluate the efficacy and safety of REGRANEX® Gel compared with placebo when applied for up to 52 consecutive weeks to recurring or non-healing ulcers of the ankle or foot related to diabetes.
NCT00389636 ↗ TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers Unknown status Solsys Medical LLC N/A 2006-09-01 Patients will be randomized to receive TheraGauze alone or with Regranex to treat diabetic foot ulcer condition. The purpose of the study is provide the sponsor with pilot information regarding the ability of TheraGauze to promote wound healing on its own and to examine synergy with Regranex in the treatment of diabetic foot ulcers.
NCT00389636 ↗ TheraGauze™ Alone and Regranex®Gel 0.01% Plus TheraGauze™ in the Treatment of Wagner Stage I Diabetic Foot Ulcers Unknown status Soluble Systems, LLC N/A 2006-09-01 Patients will be randomized to receive TheraGauze alone or with Regranex to treat diabetic foot ulcer condition. The purpose of the study is provide the sponsor with pilot information regarding the ability of TheraGauze to promote wound healing on its own and to examine synergy with Regranex in the treatment of diabetic foot ulcers.
NCT00446472 ↗ Evaluation of Windowed Casts With and Without Regranex® Gel for Healing Diabetic Neuropathic Ulcers Unknown status Heritage Medical Research Institute N/A 2007-04-01 The objective of this study is to compare the effectiveness and safety of windowed casts with Regranex® (topical becaplermin gel) versus placebo (inactive medication) for treatment of diabetic ulcers on the legs and feet.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for REGRANEX

Condition Name

Condition Name for REGRANEX
Intervention Trials
Diabetes Mellitus 2
Diabetic Foot 2
Diabetic Foot Ulcers 2
Diabetic Neuropathies 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for REGRANEX
Intervention Trials
Foot Ulcer 6
Diabetic Foot 6
Ulcer 5
Diabetic Neuropathies 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for REGRANEX

Trials by Country

Trials by Country for REGRANEX
Location Trials
India 6
United States 3
France 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for REGRANEX
Location Trials
New York 1
California 1
Illinois 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for REGRANEX

Clinical Trial Phase

Clinical Trial Phase for REGRANEX
Clinical Trial Phase Trials
Phase 3 2
Phase 1/Phase 2 1
Phase 1 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for REGRANEX
Clinical Trial Phase Trials
Completed 4
Unknown status 2
Withdrawn 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for REGRANEX

Sponsor Name

Sponsor Name for REGRANEX
Sponsor Trials
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2
Adocia 1
Virchow Group 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for REGRANEX
Sponsor Trials
Industry 8
Other 6
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.